Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Japan · Delayed Price · Currency is JPY

2,059.00

0.00 (0.00%)

Jul 14, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Unallocated Adjustment		-546.56M	-610.23M	-508.12M	-558.57M	-642.66M
Others		698.18M	751.17M	657.42M	715.07M	799.69M
Others Growth		-7.05%	14.26%	-8.06%	-10.58%	10.36%
Ethical Pharmaceutical Business		58.98B	49.59B	43.15B	37.01B	30.02B
Ethical Pharmaceutical Business Growth		18.95%	14.92%	16.60%	23.26%	-5.49%
Consumer Health Care Business		28.18B	26.00B	25.09B	22.37B	25.26B
Consumer Health Care Business Growth		8.39%	3.64%	12.14%	-11.45%	-11.37%
Total		87.31B	75.73B	68.38B	59.53B	55.44B
Total Growth		15.30%	10.74%	14.87%	7.38%	-8.25%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Europe		-	24.41B	20.15B	20.95B	15.11B
Europe Growth		-	21.11%	-3.82%	38.64%	8.43%
Japan		37.60B	36.75B	36.00B	34.86B	36.35B
Japan Growth		2.32%	2.09%	3.26%	-4.08%	-12.78%
Other Europe		23.35B	-	-	-	-
France		9.05B	-	-	-	-
UK		11.35B	9.54B	7.33B	-	-
UK Growth		18.97%	30.19%	-	-	-
Other		5.96B	5.03B	4.90B	3.71B	3.98B
Other Growth		18.60%	2.53%	31.95%	-6.72%	-17.30%
Total		87.31B	75.73B	68.38B	59.53B	55.44B
Total Growth		15.30%	10.74%	14.87%	7.38%	-8.25%